ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.

International audience

Data and Resources

Additional Info

Field Value
Source ISSN: 1942-0862
Author Dupuis-Girod, S., Ambrun, A., Decullier, E., Samson, G., Roux, A., Fargeton, A.-E., Rioufol, C., Schwiertz, V., Disant, F., Chapuis, F., Donazzolo, Y., Paintaud, G., Edery, P., Faure, F.
Maintainer CCSD
Last Updated May 5, 2026, 11:14 (UTC)
Created May 5, 2026, 11:14 (UTC)
Identifier hal-00991138
Language en
Rights https://about.hal.science/hal-authorisation-v1/
contributor Service de génétique et centre de référence pour la maladie de Rendu-Osler ; Hospices Civils de Lyon (HCL)
creator Dupuis-Girod, S.
date 2014-05-01T00:00:00
harvest_object_id 5d6eebc0-f54d-478a-9b08-ae7d62e665c1
harvest_source_id 3374d638-d20b-4672-ba96-a23232d55657
harvest_source_title test moissonnage SELUNE
metadata_modified 2026-04-02T00:00:00
relation info:eu-repo/semantics/altIdentifier/doi/10.4161/mabs.28025
set_spec type:ART